{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_4d617cd9c863725346f5cfc144a2e5d6c55f889d447a78ddba0a375ec0bf9b35","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_4d617cd9c863725346f5cfc144a2e5d6c55f889d447a78ddba0a375ec0bf9b35","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"d27b37e1020905c3af2f875d9cf609ff7812f3238e52b72cc59d1fbc83973a16","published":"Tue, 30 Jun 2026 00:00:00 -0400","receipt_hash":"d27b37e1020905c3af2f875d9cf609ff7812f3238e52b72cc59d1fbc83973a16","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"d27b37e1020905c3af2f875d9cf609ff7812f3238e52b72cc59d1fbc83973a16","observed_at":"2026-06-30T04:43:04.087680Z","parent_run_hash":"74f7ab392cc702044101fe24a76a2fdad11164cd79ce725aad6c446a477e89c5","published":"Tue, 30 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2606.28692v1 Announce Type: new \nAbstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy. It is inherently iterative: candidates are weighed against many constraints, revised as evidence emerges, and grounded in verifiable sources. Here we introduce ATHENA-R1, an AI agent for treatment reasoning across all FDA approved drugs since 1939, trained by reinforcement learning over a universe of 212 biomedical tools. At each step it identifies missing information, selects and runs relevant tools, and incorporates the evidence. To train it without human-annotated traces, we build a two-level self-learning framework: multi-agent systems construct the tools, tasks, and reasoning trajectories for supervised fine-tuning, then reinforcement learning with scientific feedback rewards reasoning quality (evidence gathering, grounded tool use, l","title":"An AI agent for treatment reasoning over a biomedical tool universe","url":"https://arxiv.org/abs/2606.28692","vendor":"arxiv_cs_ai"},"summary":"arXiv:2606.28692v1 Announce Type: new \nAbstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy. It is inherently iterative: candidates are weighed against many constraints, revised as evidence emerges, and grounded in verifiable sources. Here we introduce ATHENA-R1, an AI agent for treatment reasoning across all FDA approved drugs since 1939, trained by reinforcement learning over a universe of 212 biomedical tools. At each step it identifies missing information, selects and runs relevant tools, and incorporates the evidence. To train it without human-annotated traces, we build a two-level self-learning framework: multi-agent systems construct the tools, tasks, and reasoning trajectories for supervised fine-tuning, then reinforcement learning with scientific feedback rewards reasoning quality (evidence gathering, grounded tool use, l","title":"An AI agent for treatment reasoning over a biomedical tool universe","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-30T04:43:04Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2606.28692"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:92240f83745a467218fa54c068abeba9d6140ce2d485b6f60c756b4f4952ffffe085d38c59489793c04c6180b18d853f012af84952af165a1ecf9e9ab9fcba0a","signer":"crovia.substrate","subject":{"observed_at":"2026-06-30T04:43:04Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2606.28692"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"2403e3d693cf5309aacc527aa7978b8581d2c944695f6a3ac24642cda98dee1b","leaf_index":264607,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"8866ed1d21994a88c80a91542ea70f2b43dfd8dc25edd3bf4db24aa24434407c","side":"left"},{"sibling":"f7a1982a67452647c5fe1989ad99574049a617fff6d5b10280217cafcfdf7ce7","side":"left"},{"sibling":"ce242d273e471b58c89326cb88dcbb18b9702ff58181e13ad05cb64352585451","side":"left"},{"sibling":"360e7fa950ad2a94eeaa3fe1a8ede645f09acded8ce9b3001545284a6be9c222","side":"left"},{"sibling":"418e04e827cff386694cd5201831f808370c8bb4906b90e69e9c189f26aade68","side":"left"},{"sibling":"37d9a5217eccfeea5219a14fbc95b441a7bcaca3712a0dd5711230bd8153e3c5","side":"right"},{"sibling":"72ca31d723b9813d5bddaf5e89440ca5d3bb8898e526bd86c03fbafd589a70de","side":"right"},{"sibling":"0adb33f90b5325f1bcd6d9d08abc79306f0275cec357b6a5d5a9aeb8dae006eb","side":"left"},{"sibling":"a18aac5bf38684ad71f816483beee037e0b60af41587ea19ba92b263e2076d3e","side":"left"},{"sibling":"e814db3b1e34c91aa2d674ee041f8e093e00869024c9f6f8c4d72cab70c3a87e","side":"right"},{"sibling":"23994bf0974e5c9c7f63a61b4f0a48b0ca756a4adc34a8f85f878e774c37dfbe","side":"right"},{"sibling":"f9b4bed84fa6990c71ad2887c91bda183001f05f6b648f21d1273045a26b11fd","side":"left"},{"sibling":"173d2dc4b29ee04ea41d6d0ebc334c4bc2d46e7ee4230c94765413f24fb4bc42","side":"right"},{"sibling":"112461f7c0ec411116fb5c6c90fe95cea9d8f188b9fe08afe25a837ac02d0071","side":"right"},{"sibling":"ea9488204352c49db8f7daf05eefcd7628ecf9413830346674801a99d0654a94","side":"right"},{"sibling":"6261c13b9922cb657f10d1e5d36ec15d8771cf8766e36c61dcbffb7bed57e396","side":"right"},{"sibling":"fa19aa3faf287618b820bcfceebb366152ad521dd20ef9f51e977816663e448b","side":"right"},{"sibling":"c32f943406b62d1fc59b7f7e243492174c8e1caba8c8a2705f86c773315736e0","side":"right"},{"sibling":"1cecb7f447febd025aac272837c80de218aecc6485d2395a509b2a1f1b9c746e","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":265374,"merkle_root":"9636001ecab173cb6af10dc7c71eb14585daa62f9c0a6f027046f05633156891","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260630T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-30T05:38:03Z","sig_algorithm":"ed25519","signature":"6d4b8fd9b9da856cbb5fba7540877c6a63fa18a5ec3eaf28dc4d6d1c64921c9c0565f8c95f4b7aec0e7744fd7754844f051baf863db708cad768765b416a7b0c","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_4d617cd9c863725346f5cfc144a2e5d6c55f889d447a78ddba0a375ec0bf9b35"}}